EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial

Meryam El Issaoui iD, Marlene Elmelund, Niels Klarskov

BJU International · 2025

DOI: 10.1111/bju.16647 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift BJU International, 2025. Verfasst von Meryam El Issaoui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Herlev and Gentofte University Hospital, Herlev, Denmark. Hauptthemen laut MEDLINE: Anesthetics, Local, Botulinum Toxins, Type A, Lidocaine, Procedural Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Herlev and Gentofte University Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX‐A) injections for overactive bladder. Patients and Methods This single‐centre, randomised, double‐blind, placebo‐controlled two period crossover trial was conducted on women scheduled for BTX‐A injections at our outpatient urogynaecology clinic between September 2022 and May 2024. Patients were randomly assigned (1:1) to receive either alkalinised lidocaine or placebo during the first treatment period. Alkalinised lidocaine solution comprised lidocaine hydrochloride (20 mg/mL, 20 mL), sodium hydrogen carbonate (1 mmoL/mL, 10 mL), and sodium chloride (9 g/L, 10 mL). The matching placebo was sodium chloride (9 g/L, 40 mL). The primary outcome measure was procedural pain rated on a 100‐mm visual analogue scale (VAS). Secondary outcomes included adverse effects such as post‐void residual urine volumes requiring catheterisation, urinary tract infection, haematuria 1 week after treatment, and patient satisfaction measured on a 5‐point scale. During the second treatment period, patients received the alternative intervention.

Results

We enrolled 50 patients, of which 41 were eligible for per‐protocol analyses. The mean VAS score was significantly lower following intravesical alkalinised lidocaine (mean 21.3 mm, 95% confidence interval [CI] 14.7–27.8 mm) compared to placebo (mean 41.6 mm, 95% CI 35.0–48.1 mm) with a mean difference of −20.3 mm (95% CI −29.2 to −11.5 mm; P < 0.001). Adverse events and patient satisfaction did not significantly differ between the alkalinised lidocaine and placebo treatments ( P = 0.825 and P = 0.138, respectively).

Conclusions

Intravesical instillation of alkalinised lidocaine before BTX‐A injections significantly reduced VAS pain scores compared to placebo ( ClinicalTrials.gov identifier: NCT05415865).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anesthetics, LocalBotulinum Toxins, Type ALidocaineProcedural PainUrinary Bladder, OveractiveAdultAgedFemaleHumansMiddle AgedAdministration, IntravesicalCross-Over StudiesDouble-Blind MethodPain Measurement

Stichwörter der Autor:innen

alkalinised lidocainecrossover studyintravesical administrationlocal anaestheticsonabotulinumtoxinAoveractive bladder syndromepainrandomised controlled trialvisual analogue scale

Substanzen

Anesthetics, LocalBotulinum Toxins, Type ALidocaineonabotulinum toxin A

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Herlev and Gentofte University Hospital, Herlev, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Gynecology and Obstetrics, Amager and Hvidovre Hospital, Hvidovre, Denmark.

ORCID-Profile: Meryam El Issaoui

Förderung

  • Herlev and Gentofte University Hospital Research Fund

Zitieren

APA

El Issaoui, M., Elmelund, M., & Klarskov, N. (2025). Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial. BJU International. https://doi.org/10.1111/bju.16647

Vancouver

El Issaoui M, Elmelund M, Klarskov N. Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial. BJU International. 2025. doi:10.1111/bju.16647

BibTeX
@article{ElIssaoui2025,
  author = {El Issaoui, Meryam and Elmelund, Marlene and Klarskov, Niels},
  title = {Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial},
  journal = {BJU International},
  year = {2025},
  doi = {10.1111/bju.16647}
}
Kostenlos starten →